Skip to main content
SpringerLink
Log in

The hormonal concept of interferon

  • Brief Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aguet, M., Gresser, I., Hovanessian, A. G., Bandu, M.-T., Blanchard, B., Blangy, D.: Specific high-affinity binding of125I-labeled mouse interferon to interferon resistant embryonal carcinoma cellsin vitro. Virology114, 585–588 (1981).

    Google Scholar 

  2. Antoniades, H. N., Owen, A. J.: Growth factors and regulation of cell growth. Ann. Rev. Med.33, 445–463 (1982).

    Google Scholar 

  3. Balkwill, F. R.: Interferons as cell-regulatory molecules. Cancer Immunol. Immunother.7, 7–14 (1979).

    Google Scholar 

  4. Baron, S.: The biological significance of the interferon system. In:Finter, N. B. (ed.), Interferons, 268–293. Amsterdam: North-Holland 1966.

    Google Scholar 

  5. Blalock, J. E., Harp, C.: Interferon and adrenocorticotropic hormone induction of steroidogenesis, melanogenesis and antiviral activity. Arch. Virol.67, 45–49 (1981).

    Google Scholar 

  6. Bocci, V.: Production and role of interferon in physiological conditions. Biol. Rev.56, 49–85 (1981).

    Google Scholar 

  7. Borecky, L.: Twenty years after discovery of interferon: The progress and the persistent problems. Acta biol. med. germ.38, 709–731 (1979).

    Google Scholar 

  8. Bradshaw, R. A., Rubin, J. S.: Polypeptide growth factors: Some structural and mechanistic considerations. J. supramol. Struct.14, 183–199 (1980).

    Google Scholar 

  9. Brouty Boyé, D., Zetter, B. R.: Inhibition of cell motility by interferon. Science208, 516–518 (1980).

    Google Scholar 

  10. Calvet, M. C., Gresser, I.: Interferon enhances the excitability of cultured neurons. Nature278, 558–560 (1979).

    Google Scholar 

  11. Chany, C.: Membrane-bound interferon specific cell receptor system: Role in the establishment and amplification of the antiviral state. Biomedicine24, 148–157 (1976).

    Google Scholar 

  12. Chany, C., Mathieu, D., Gregoire, A.: Induction of delta 4-3 ketosteroid synthesis by interferon in mouse adrenal tumor cell cultures. J. gen. Virol.50, 447–450 (1980).

    Google Scholar 

  13. Chinkers, M., Cohen, S.: Purified EGF receptor-kinase interacts specifically with antibodies to Rous sarcoma virus transforming protein. Nature290, 516–519 (1981).

    Google Scholar 

  14. Chudzio, T., Inglot, A. D.: Platelet-derived growth factor (PDFG) inhibits priming in the synchronous mouse or human fibroblasts producing interferon. J. Interferon Res.1, 31–36 (1980).

    Google Scholar 

  15. de Maeyer, E., de Maeyer-Guignard, J.: Interferons as regulatory agents of the immune system. CRC Critical Reviews in Immunology2, 167–188 (1981).

    Google Scholar 

  16. Deuel, T. F., Senior, R. M., Huang, J. S., Griffin, G. L.: Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest.69, 1046–1049 (1982).

    Google Scholar 

  17. Ek, B., Westermark, B., Wasteson, A., Heldin, C. H.: Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature295, 419–423 (1982).

    Google Scholar 

  18. Epstein, L. B.: Interferons as a model lymphokine. Fed. Proc.40, 56–61 (1981).

    Google Scholar 

  19. Epstein, L. B., Rose, E. M., Mc Manus, N. H., Li, C. H.: Absence of functional and structural homology of natural and recombinant human leukocyte interferon (α IFN) with human α ACTH and β endorphin. Biochem. biophys. Res. Comm.104, 341–346 (1981).

    Google Scholar 

  20. Erikson, E., Shealy, D. J., Erikson, R. L.: Evidence that viral transforming gene products and epidermal growth factor stimulate phosphorylation of the same cellular protein with similar specificity. J. biol. Chem.256, 11381–11384 (1981).

    Google Scholar 

  21. Evinger, M., Maeda, S., Pestka, S.: Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity. J. biol. Chem.256, 2113–2114 (1981).

    Google Scholar 

  22. Feldmann, M., Schreier, M. H. (eds.): Lymphokines, Vol. 5: Monoclonal T cells and their products, 1–496. New York: Academic Press 1982.

    Google Scholar 

  23. Fowler, A. H., Reed, C. D., Giron, D. J.: Identification of an interferon in murine placentas. Nature286, 266–267 (1980).

    Google Scholar 

  24. Gospodarowicz, D.: Epidermal and nerve growth factors in mammalian development. Ann. Rev. Physiol.43, 251–263 (1981).

    Google Scholar 

  25. Gresser, I.: On the mechanisms of the antitumor effects of interferon. Texas Rep. Biol. Med. (in press, 1982).

  26. Gresser, I., Aguet, M., Morel-Maroger, L., Woodrow, D., Puvion-Dutilleul, F., Guillon, J. C., Maury, C.: Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Amer. J. Path.102, 396–402 (1981).

    Google Scholar 

  27. Gresser, I., Tovey, M. G.: Antitumor effects of interferons. Biochem. biophys. Acta516, 231–247 (1981).

    Google Scholar 

  28. Gutterman, J. U., Fine, S., Quesada, J., Horning, S. J., Levine, J. D., Alexanian, R., Bernhardt, L., Kramer, M., Spiegel, H., Colburn, W., Trown, P., Merigan, T., Dziewanowski, Z.: Recombinant leukocyte A interferon: Pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann. Int. Med.96, 549–556 (1982).

    Google Scholar 

  29. Heldin, C. H., Westermark, B., Wasteson, A.: Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. J. Cell Physiol.105, 235–246 (1980).

    Google Scholar 

  30. Hollenberg, M. D.: Membrane receptors and hormone action II. New perspectives for receptor-modulated cell function. Trends Pharmacol. Sci.3, 25–28 (1982).

    Google Scholar 

  31. Inglot, A. D.: Interferons and growth factors viewed as two families of hormones with opposing actions. Texas Rep. Biol. Med.41, 402–410 (1982).

    Google Scholar 

  32. Inglot, A. D., Inglot, O.: Platelet-derived growth factor (PDGF) enhances the growth of Moloney sarcoma virus-induced tumors in mice. Arch. Immunol. Ther. Exp.29, 431–437 (1981).

    Google Scholar 

  33. Inglot, A. D., Inglot, O.: Hormonal-like modulation of growth of Moloney sarcoma virus-induced tumors by interferon and platelet derived growth factor. Arch. Immunol. Ther. Exp. (in press, 1982).

  34. Inglot, A. D., Oleszak, E., Kisielow, B.: Antagonism in action between mouse or human interferon and platelet growth factor. Arch. Virol.63, 291–296 (1980).

    Google Scholar 

  35. Kauppila, A., Cantell, K., Janne, O., Kokko, E., Vihko, R.: Serum sex steroid and peptide hormone concentrations and endometrial estrogen and progestin receptor levels during administration of human leukocyte interferon. Int. J. Cancer29, 291–294 (1982).

    Google Scholar 

  36. Kiefer, H., Blume, A. J., Kaback, H. R.: Membrane potential changes during mitogenic stimulation of mouse spleen lymphocytes. Proc. Natl. Acad. Sci. U.S.A.77, 2200–2204 (1980).

    Google Scholar 

  37. Kohn, L. D.: Relationship in the structure and function of receptors for glycoprotein hormones, bacterial toxins and interferon. In:Cautrecasas, P., Greaves, M. S. (eds.), Receptor and recognition. Series A5, 135–212. London: Chapman and Hall 1978.

    Google Scholar 

  38. Krishnamurti, C., Besançon, F., Justesen, J., Poulsen, K., Ankel, H.: Inhibition of mouse fibroblast interferon by gangliosides. Differential effects on biological activity and on induction of (2′–5′)-oligoadenylate synthetase. Eur. J. Biochem.124, 1–6 (1982).

    Google Scholar 

  39. Lebon, P., Girard, S., Thepot, F., Chany, C.: The presence of alpha-interferon in human amniotic fluid. J. gen. Virol.59, 393–396 (1982).

    Google Scholar 

  40. Lengyel, P.: Enzymology of interferon action — A short survey. In:Pestka, S. (ed.), Methods in Enzymology Vol. 79, 135–148. London: Academic Press 1981.

    Google Scholar 

  41. Lin, S. L., Ts'o, P. O. P., Hollenberg, M. D.: The effect of interferon on epidermal growth factor action. Biochem. biophys. Res. Comm.96, 168–174 (1980).

    Google Scholar 

  42. Lindenmann, J.: The role of interferon in natural resistance. In:Gresser, I. (ed.), Interferon 1981, Vol. 3, 1–12. London: Academic Press 1981.

    Google Scholar 

  43. Matsubara, S., Suzuki, M., Nakamura, M., Edo, K., Ishida, N.: Isolation of an inhibitor of type II interferon induction from tumor ascitic fluid. Cancer Res.40, 2534–2538 (1980).

    Google Scholar 

  44. Mc Neil, T. A., Fleming, W. A.: Effect of interferon on hemopoietic colony-forming cells. Texas Rep. Biol. Med.35, 343–349 (1977).

    Google Scholar 

  45. Mogensen, K. E., Bandu, M. T., Vignaux, F., Aguet, M., Gresser, I.: Binding of125I-labelled human α interferon to human lymphoid cells. Int. J. Cancer28, 575–582 (1981).

    Google Scholar 

  46. Nandi, S., Yang, J., Richards, J., Guzman, R., Rodriguez, R., Imagawa, W.: Role of growth factors and classical hormones in the control of growth and function of mammary tissues. In:Ishii, S., Hirano, T., Wada, M. (eds.), Hormones, adaptation and evolution, 145–155. Tokyo: Japan. Sci. Soc. Press, Berlin-Heidelberg-New York: Springer 1980.

    Google Scholar 

  47. Oleszak, E., Inglot, A. D.: Platelet-derived growth factor (PDGF) inhibits antiviral and anticellular action of interferon in synchronized mouse or human cells. J. Interferon Res.1, 37–48 (1980).

    Google Scholar 

  48. Owen, A. J., Geyer, R. P., Antoniades, H. N.: Human platelet-derived growth factor stimulates amino acid transport and protein synthesis by human diploid fibroblasts in plasma-free media. Proc. natl. Acad. Sci. U.S.A.79, 3203–3207 (1982).

    Google Scholar 

  49. Paskind, M., Weinberg, G., Baltimore, D.: Dependence of Moloney leukemia virus production on cell growth. Virology67, 242–248 (1975).

    Google Scholar 

  50. Pfeffer, L. M., Landsberger, F. R., Tamm, I.: Beta-interferon-induced time-dependent changes in the plasma membrane lipid bilayer of cultured cells. J. Interferon Res.1, 613–620 (1981).

    Google Scholar 

  51. Roth, J., Le Roith, D., Shiloach, J., Rosenzweig, J. L., Lesniak, M. A., Havrankova, J.: The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers. Implication for mammalian biology. N. Engl. J. Med.306, 523–527 (1982).

    Google Scholar 

  52. Scott, G., Secher, D. S., Flowers, D., Bate, J., Cantell, K., Tyrrell, D. A. J.: Toxicity of inteferon. Brit. Med. J.282, 1345–1348 (1981).

    Google Scholar 

  53. Seppa, H., Grotendorst, G., Seppa, S., Schiffmann, E., Martin, G. R.: Platelet-derived growth factor is chemotactic for fibroblasts. J. Cell. Biol.92, 584–588 (1982).

    Google Scholar 

  54. Siegal, G. P., Thorgeirsson, U. P., Russo, R. G., Wallace, D. M., Liotta, L. A., Berger, S. L.: Interferon enhancement of the invasive capacity of Ewing sarcoma cellsin vitro. Proc. Soc. natl. Acad. Sci. U.S.A.79, 4064–4068 (1982).

    Google Scholar 

  55. Slate, D. L., Ruddle, F. H.: Genetic control of the interferon system. In:Gresser, I. (ed.), Interferon 1981, Vol. 3, 65–76. London: Academic Press 1981.

    Google Scholar 

  56. Stewart II, W. E.: The interferon system, 1–421. Wien-New York: Springer 1979.

    Google Scholar 

  57. Stringfellow, D. A.: Murine leukemia: Depressed response to interferon induction correlated with a serum hyporeactive factor. Infec. Immunol.13, 392–404 (1976).

    Google Scholar 

  58. Taylor-Papadimitriou, J.: Effects of interferons on cell growth and function. In:Gresser, I. (ed.), Interferon 1980, Vol. 2, 13–46. London: Academic Press 1980.

    Google Scholar 

  59. Taylor-Papadimitriou, J., Shearer, M., Rozengurt, E.: Inhibitory effect of interferon on cellular DNA synthesis: Modulation by pure mitogenic factors. J. Interferon Res.1, 401–409 (1981).

    Google Scholar 

  60. Todaro, G. J., De Larco, J. E., Fryling, C., Johnson, P. A., Sporn, M. B.: Transforming growth factors (TGFs): Properties and possible mechanisms of action. J. supramol. Struct.15, 287–301 (1981).

    Google Scholar 

  61. Twardzik, D. R., Todaro, G. J., Marquardt, H., Reynolds, F. H., Stephenson, J. R.: Transformation induced by Abelson murine leukemia virus involves production of a polypeptide growth factor. Science216, 984–896 (1982).

    Google Scholar 

  62. Verhaegen-Lawalle, M., Kuwata, T., Zhang, Z. X., De Clercq, E., Cantell, K., Content, J.: 2–5 A synthetase activity induced by interferon α, β, and γ in human cell lines differing in their sensitivity to the anticellular and antiviral activities of these interferons. Virology117, 425–434 (1982).

    Google Scholar 

  63. Weissmann, C.: The cloning of interferon and other mistakes. In:Gresser, I. (ed.), Interferon 1981, Vol. 3, 101–134. London: Academic Press 1981.

    Google Scholar 

  64. Yip, I. K., Barrowclough, B. S., Urban, C., Vilček, J.: Purification of two subspecies of human γ (immune) interferon. Proc. natl. Acad. Sci. U.S.A.79, 1820–1824 (1982).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Tumor Virology, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

    Anna D. Inglot

Authors
  1. Anna D. Inglot
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inglot, A.D. The hormonal concept of interferon. Archives of Virology 76, 1–13 (1983). https://doi.org/10.1007/BF01315699

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01315699

Keywords

Search

Navigation